Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2008
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008WO2008076046A8 Novel 2-amino-5, 5-diaryl-imidazol-4-ones
11/06/2008WO2007134187A3 Processes for nitration of n-substituted imidazoles
11/06/2008WO2007126765A3 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
11/06/2008US20080275252 Atipamezole Hydrochloride Crystallization Method
11/06/2008US20080275251 acyloxy imidazole intermediates for making C-14 oxycarbonyl carbamate pleuromutilin derivative antibiotics; making the intermediates from 4-aminocyclohexanol and 1,1'-carbonyldiimidazole; produce antibiotic on cost efficiency, non-toxic reagents, and proceeds in high yields and high purities
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275100 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient
11/06/2008US20080275099 Solid Forms of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080275061 Method for controlling particular insect pests by applying anthranilamide compounds
11/06/2008US20080275035 Nitroimidazole Compounds
11/06/2008US20080275016 For drug resistant cancers; antiinflammatory agents;degenerative or vascular diseases; blocking nitrogen oxide so growth of tumors is suppressed
11/06/2008US20080275003 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
11/06/2008DE102006035830A9 Lösungssystem auf der Basis geschmolzener ionischer Flüssigkeiten, dessen Herstellung sowie Verwendung zur Herstellung regenerierter Kohlenhydrate Solution system based molten ionic liquids, its preparation and use for the production of regenerated carbohydrates
11/06/2008CA2683866A1 Bridged six-membered ring compounds
11/06/2008CA2682508A1 Dual-acting antihypertensive agents
11/05/2008EP1988090A1 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
11/05/2008EP1988081A1 Binding inhibitor of sphingosine-1-phosphate
11/05/2008EP1988080A1 Insecticidal substituted 2-aminoindanes
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1987009A1 Cyclourea compounds as calcium channel blockers
11/05/2008EP1986638A2 Cb1 antagonists and inverse agonists
11/05/2008EP1986498A2 Insecticidal substituted amino heterocyclic and heteroaryl derivatives
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008EP1053227B1 Ppar-gamma modulators
11/05/2008CN101298442A Acidamide compound based on 2-(2í»-hydroxyphenyl) benzoxazole, preparation and use thereof
11/05/2008CN101298436A Fluorinating agent and method for producing fluorine-containing compound using the same
11/05/2008CN100430411C Activators for oligonucleotide synthesis
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446213 Cationic, water-soluble polythiophene derivatives, which can readily transduce oligonucleotide hybridization into a clearly interpretable optical (colorimetric, fluorescent or luminescent) or electrical signal
11/04/2008US7446209 Diazotizing a blocked 5-amino-1H-imidazole-4-carboxamide; hydrolysis; antitumor agents
11/04/2008US7446129 Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, then react resulting nucleophilic PDE4 inhibitor with benzylating agent, e.g., benzyl bromide; no emetogenic side effects
11/04/2008US7446120 (3mercapta-1,2,4-triazole-5yl)-phenyl-tertbutane; cadherin cell adhesion recognition sequence His-Ala-Val within a cyclic peptide ring; enhance drug delivery to cells in need (tumor, Schwann cells, oligodendrocytes, graft rejection, epidermal patches); anticarcinogenic, angiogenesis inhibitor
10/2008
10/30/2008WO2008130313A1 Imidazole derivatives as modulators of the gaba receptor for the treatment of gastrointestinal disorders
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008WO2008128987A1 Novel inhibitors
10/30/2008WO2008128986A1 Urea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128985A1 Thiourea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128983A1 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128981A1 Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
10/30/2008US20080269305 R)-N-{2-Butyl-3-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl]-3H-imidazol-4-ylmethyl}-2-(2-hydroxycarbamoyl-3-phenyl-propionylamino)succinamic Acid; AT1 receptor antagonist and neprilysin (NEP) enzyme inhibition activity; hypertension, heart failure
10/30/2008US20080269283 Arylsulfones and uses related thereto
10/30/2008US20080269280 Antiinflammatory agents; rheumatic diseases; multiple sclerosis
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof
10/30/2008US20080269216 Gastrointestinal disorders; irritable bowel syndrome
10/30/2008US20080268509 Methods of labeling polynucleotides with energy transfer dyes
10/30/2008US20080267912 Novel inhibitors of glutaminyl cyclase
10/30/2008US20080265758 Organometallic complexes and organic electroluminescence device using the same
10/29/2008EP1984342A2 Novel solid forms of (4r)-1-[4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl]-1,2,3,5-tetrahydro-spiro[4h-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid
10/29/2008CN101296911A Arylurea derivatives as modulators of chemokine receptor activity
10/29/2008CN100429203C Dyeing compsn. for kerationous fibres comprising particular dicationic diazo dye
10/28/2008US7442717 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure
10/28/2008US7442702 Prostaglandin agonists
10/28/2008CA2546602C Monoacyl-substituted guanidines
10/28/2008CA2291160C Combination therapy for modulating the human sexual response
10/23/2008WO2008128045A1 Solid forms of (e) -1- (4- ( (1r, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl)ethanone oxime
10/23/2008WO2008128041A2 Methods of preparing 1- (4- (1-hydroxyalkyl) -1h- imidazol-2- yl) ethanone oxime compounds
10/23/2008WO2008127727A1 Biaryl compositions and methods for modulating a kinase cascade
10/23/2008WO2008125589A2 Tris(heterocyclyl) metal complexes as bleach catalysts
10/23/2008WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof
10/23/2008WO2008101881A3 Alkyl h-phosphonates of n,n'-dialkylimidazoliums and of quaternary ammoniums, and uses thereof
10/23/2008WO2008021849A3 Novel compounds as antagonists or inverse agonists at opioid receptors
10/23/2008US20080262241 Imidazole compound containing alcohol and oxime groups
10/23/2008US20080262066 azole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders.
10/23/2008US20080262065 Novel inhibitors of glutaminyl cyclases
10/23/2008US20080262064 Novel Compounds For The Treatment Of GI Disorders 682
10/23/2008US20080262063 Novel inhibitors of glutaminyl cyclase
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262015 therapeutically active 2,4,5-trisubstituted imidazole compounds; alone or in combination; high antineoplastic activity, low systemic toxicity and low mutagenicity on normal cells; inhibitors of p38 MAP kinase; modulators of multi-drug resistance in cancer cells
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261985 treating a disorder characterized by the overexpression of iNOS or COX-2 genes; rheumatoid arthritis, inflammatory bowel disease, lupus, multiple sclerosis, or psoriasis; cancer
10/23/2008US20080261917 Prodrug; novel series of compounds which inhibit the MDM2-p53 interaction and have in vitro activity exerting an anti-tumour effect; cancer
10/23/2008US20080260829 Bone morphogenic proteins (bmp); cell adhesion modulating agent; peptidomimetics of cyclic peptides comprising classical cadherin cell adhesion recognition (CAR) sequences; modulate cell adhesion and improve drug delivery
10/23/2008CA2683963A1 Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime
10/23/2008CA2683445A1 Methods of preparing imidazole-based compounds
10/22/2008EP1982716A1 Novel histidine derivative
10/22/2008EP1981880A2 Use of 4-imidazole derivatives for cns disorders
10/22/2008EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
10/22/2008EP1981854A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/22/2008EP1981853A1 Substituted imidazoles and their use as pesticides
10/22/2008EP1981852A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1981499A1 Use of 2-imidazoles for the treatment of cns disorders
10/22/2008EP1981497A2 Use of substituted 2-imidazole of imidazoline derivatives
10/22/2008EP1756089B1 Mercaptoimidazoles as ccr2 receptor antagonists
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008EP1425265B1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists
10/22/2008CN101291950A 新系列咪唑基取代的类固醇和茚满-1-酮衍生物 New series of imidazolyl substituted steroidal and indan-1-one derivative
10/22/2008CN101289485A Absorption of nucleic acids to solid phases under low-salt conditions
10/22/2008CN100427472C Aryl-heteroaromatic products, compositions containing same and use thereof
10/22/2008CN100427471C Process for preparing hydantoin
10/22/2008CN100427470C Synthesis technology of 1,3-dimethyl-2-chloroimidazoline chloride
10/21/2008US7439395 Two-step process for preparation of guanidinium salts having an anion selected from sulfonate, sulfate, imide, methanide, carboxylate, phosphate, phosphinate, phosphonate, borate, thiocyanate, perchlorate, fluorosilicate or nitrate;1,3-dimethyl-2-chloroimidazolidinium nitrate; simplification
10/21/2008US7439383 Sodium channel blockers
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 345